CGX, a traditional Korean medicine ameliorates concanavalin A-induced acute liver injury

Food and Chemical Toxicology

Volumn 48, Issue 12, 2010, Pages 3308-3315

  Shin, Jang Woo ^a   Wang, Jing Hua ^a   Kim, Hyeong Geug ^a   Park, Hye Jung ^a   Bok, Hee Sung ^b   Son, Chang Gue ^a  

^a Daejeon University   (South Korea)

^b Kyoungbang Pharm   (South Korea)

Author keywords

Acute liver injury; Antioxidant; CGX; Con A; Hepatoprotective

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATRACTYLENOLIDE; AURANTIIN; CGX; CONCANAVALIN A; CYTOKINE; FLAVONOID; GAMMA INTERFERON; GLUTATHIONE; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; PONCIRIN; ROSMARINIC ACID; SCOPARONE; SCOPOLETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL POPULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; DRUG EFFECT; DRUG FORMULATION; DRUG MECHANISM; DRUG MIXTURE; DRUG STRUCTURE; HELPER CELL; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; KOREAN MEDICINE; LIPID PEROXIDATION; LIVER CELL DAMAGE; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PROTEIN DEPLETION;

ANIMALS; BODY WEIGHT; CATALASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONCANAVALIN A; DRUG-INDUCED LIVER INJURY; GLUTATHIONE; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; LIVER; LIVER FUNCTION TESTS; LYMPHOCYTE SUBSETS; MALE; MALONDIALDEHYDE; MASS SPECTROMETRY; MEDICINE, KOREAN TRADITIONAL; MICE; MICE, INBRED BALB C; ORGAN SIZE; PEPTIDE MAPPING; PLANT EXTRACTS; SPLEEN; THYMUS GLAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78049416402     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.08.025     Document Type: Article

References (27)

1. Ajuebor M.N., Aspinall A.I., Zhou F., Le T., Yang Y., Urbanski S.J., Sidobre S., Kronenberg M., Hogaboam C.M., Swain M.G. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. J. Immunol. 2005, 174:8027-8037.
2. Ajuebor M.N., Wondimu Z., Hogaboam C.M., Le T., Proudfoot A.E., Swain M.G. CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis. Am. J. Pathol. 2007, 170:1975-1988.
3. Amalia P.M., Possa M.N., Augusto M.C., Francisca L.S. Quercetin prevents oxidative stress in cirrhotic rats. Dig. Dis. Sci. 2007, 52:2616-2621.
4. Beers R.F., Siezer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 1952, 195:133-140.
5. Beldi G., Wu Y., Banz Y., Nowak M., Miller L., Enjyoji K., Haschemi A., Yegutkin G.G., Candinas D., Exley M., Robson S.C. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Hepatology 2008, 48:841-852.
6. Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J. Gen. Intern. Med. 2008, 23:854-859.
7. Bonder C.S., Ajuebor M.N., Zbytnuik L.D., Kubes P., Swain M.G. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J. Immunol. 2004, 172:45-53.
8. Cho J.H., Lee Y.Y., Seo S.H., Yoo H.S., Choi W.J., Lee Y.W., Son C.G., Cho C.K. A clinical report about 57 patients with chronic liver disease. Korean J. Orient. Med. 2000, 21:112-121.
9. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
10. Hu X.P., Shin J.W., Wang J.H., Cho J.H., Son J.Y., Cho C.K., Son C.G. Antioxidative and hepatoprotective effect of CGX, an herbal medicine, against toxic acute injury in mice. J. Ethnopharmacol. 2008, 120:51-55.
11. Inao M., Mochida S., Matsui A., Eguchi Y., Yulutuz Y., Wang Y., Naiki K., Kakinuma T., Fujimori K., Nagoshi S., Fujiwara K. Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis. J. Hepatol. 2004, 41:584-591.
12. Kaneko Y., Harada M., Kawano T., Yamashita M., Shibata Y., Gejyo F., Nakayama T., Taniguchi M. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 2000, 191:105-114.
13. Levy C., Seeff L.D., Lindor K.D. Use of herbal supplements for chronic liver disease. Clin. Gastroenterol. Hepatol. 2004, 2:947-956.
14. Louis H., Le Moine O., Peny M.O., Quertinmont E., Fokan D., Goldman M., Deviere J. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 1997, 25:1382-1389.
15. Miller A.L. Antioxidant flavonoids: structure, function and clinical usage. Altern. Med. Rev. 1996, 1:103-111.
16. Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., Satoh S., Niwa M., Senoh H., Fujiwara H. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 1994, 179:1529-1537.
17. Nakashima H., Kinoshita M., Nakashima M., Habu Y., Shono S., Uchida T., Shinomiya N., Seki S. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice. Hepatology 2008, 48:1979-1988.
18. Shin J.W., Son J.Y., Oh S.M., Han S.H., Wang J.H., Cho J.H., Cho C.K., Yoo H.S., Lee Y.W., Lee M.M., Hu X.P., Son C.G. An herbal formula, CGX, exerts hepatotherapeutic effects on dimethylnitrosamine-induced chronic liver injury model in rats. World J. Gastroenterol. 2006, 12:6142-6148.
19. Shirin H., Aeed H., Alin A., Matas Z., Kirchner M., Brazowski E., Goldiner I., Bruck R. Inhibition of immune-mediated concanavalin a-induced liver damage by free-radical scavengers. Dig. Dis. Sci. 2010, 55:268-275.
20. Stickel F., Schuppan D. Herbal medicine in the treatment of liver diseases. Dig. Liver. Dis. 2007, 39:293-304.
21. Tagawa Y., Kakuta S., Iwakura Y. Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis. Eur. J. Immunol. 1998, 28:4105-4113.
22. Tiegs G., Hentschel J., Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 1992, 90:196-203.
23. Toyabe S., Seki S., Iiai T., Takeda K., Shirai K., Watanabe H., Hiraide H., Uchiyama M., Abo T. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J. Immunol. 1997, 159:1537-1542.
24. Wang J.H., Shin J.W., Son J.Y., Cho J.H., Son C.G. Antifibrotic effects of CGX, a traditional herbal formula, and its mechanisms in rats. J. Ethnopharmacol. 2010, 127:534-542.
25. Yasuda M., Shimizu I., Shiba M., Ito S. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 1999, 29:719-727.
26. Yumei F., Zhou Y., Zheng S., Chen A. The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells. Lab. Invest. 2006, 86:697-709.
27. Zanobbio L., Palazzo M., Gariboldi S., Dusio G.F., Cardani D., Mauro V., Marcucci F., Balsari A., Rumio C. Intestinal glucose uptake protects liver from lipopolysaccharide and d-galactosamine, acetaminophen, and alpha-amanitin in mice. Am. J. Pathol. 2009, 175:1066-1076.